A diversity committee, 896 unconscious bias trainings, 100,000 USD donations - the D&I initiatives at Sartorius North America are ongoing. Learn more about what drives Mary Lavin, President, North America, and her team and how Sartorius is taking sustained action within our company and our communities: https://bit.ly/2XK2E4t
Sartorius is expanding its production capabilities in Slovenia. The expanded site in Ajdovscina will contribute to the development and #manufacturing of market-leading products for #purification and analysis of large biomolecules, such as viruses, plasmids and #mRNA. These are used in vaccines as well as in cell and gene therapies and other advanced therapies.
At Sartorius, #diversity is about #culture. We are convinced that it is only when we are open towards all people and new perspectives that can we create innovative ideas and be successful. This is why we foster diversity at all levels within our organization. For example, even as a global company, Sartorius is still becoming more international every year: Today, more than 11,000 people from nearly 100 nations team up at our company to find creative ways that simplify the work of our customers.
Sartorius with first-quarter uptick in sales and earnings: The life science group Sartorius had an exceptionally strong start in fiscal 2021 and grew substantially in order intake, sales revenue and earnings.
